Materials and methods for treatment of allergic disease

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A61K 31/00 (2006.01) C12N 5/10 (2006.01)

Patent

CA 2599524

siRNA molecules are disclosed which target the transcription factor STAT6 and repress the expression of STAT6 mRNA, STAT6 protein and STAT6 function in lung cells. The use of STAT6 specific siRNA molecules in the treatment of allergic diseases of the respiratory tract such as asthma and rhinitis is disclosed.

L'invention concerne des molécules ARNsi qui ciblent le facteur de transcription STAT6 et bloquent l'expression de l'ARNm STAT6, de la protéine STAT6 et de la fonction STAT6 dans les cellules pulmonaires. L'invention concerne également l'utilisation des molécules d'ARNsi STAT6 spécifiques dans le traitement de maladies allergiques des voies respiratoires telles que l'asthme et la rhinite.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Materials and methods for treatment of allergic disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Materials and methods for treatment of allergic disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods for treatment of allergic disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1724177

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.